EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan

Yi-Chang Chou iD, Shih-Han Weng, Feng-Shiang Cheng, Chih-Hao Tseng, Hsiao-Yun Hu, Chieh-Hsing Liu

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70334 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Yi-Chang Chou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion and Health Education, National Taiwan Normal University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Pregnancy Outcome, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Health, Taipei City Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims To assess whether periconceptional exposure to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is associated with adverse outcomes in women with pregestational type 2 diabetes. Materials and Methods We linked Taiwan's Birth Certificate Application and National Health Insurance claims (2013–2022) to assemble a nationwide cohort of singleton births to mothers (18–50 years) with pregestational diabetes. Exposure was any GLP‐1 RA dispensed during the 90 days before and after the last menstrual period; insulin without GLP‐1 RA was the active comparator. Outcomes were major congenital malformations, stillbirth, preterm birth (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomeDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsPregnancy in DiabeticsHumansFemalePregnancyAdultTaiwanYoung AdultAdolescentInfant, NewbornMiddle AgedCohort StudiesPremature BirthInfant, Small for Gestational AgeStillbirthCongenital AbnormalitiesInsulin

Stichwörter der Autor:innen

glucagon‐like peptide‐1 receptor agonistspericonceptional exposurepregnancy outcomestype 2 diabetes mellitus

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Department of Health Promotion and Health Education, National Taiwan Normal University, Taipei, Taiwan.
  • Department of Education and Research, Taipei City Hospital, Taipei, Taiwan.
  • University of Taipei, Taipei, Taiwan.
  • Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Yi-Chang Chou

Förderung

  • Department of Health, Taipei City Government

Zitieren

APA

Chou, Y. C., Weng, S. H., Cheng, F. S., Tseng, C. H., Hu, H. Y., & Liu, C. H. (2026). Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70334

Vancouver

Chou YC, Weng SH, Cheng FS, Tseng CH, Hu HY, Liu CH. Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70334

BibTeX
@article{Chou2026,
  author = {Chou, Yi-Chang and Weng, Shih-Han and Cheng, Feng-Shiang and Tseng, Chih-Hao and Hu, Hsiao-Yun and Liu, Chieh-Hsing},
  title = {Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70334}
}
Kostenlos starten →